Detection of heterozygous mutations in BRCA1 using high density oligonucleotide arrays and two–colour fluorescence analysis
- 1 December 1996
- journal article
- Published by Springer Science and Business Media LLC in Nature Genetics
- Vol. 14 (4), 441-447
- https://doi.org/10.1038/ng1296-441
Abstract
The ability to scan a large gene rapidly and accurately for all possible heterozygous mutations in large numbers of patient samples will be critical for the future of medicine. We have designed high-density arrays consisting of over 96,600 oligonucleotides 20-nucleotides (nt) in length to screen for a wide range of heterozygous mutations in the 3.45-kilobases (kb) exon 11 of the hereditary breast and ovarian cancer gene BRCA1. Reference and test samples were co-hybridized to these arrays and differences in hybridization patterns quantitated by two-colour analysis. Fourteen of fifteen patient samples with known mutations were accurately diagnosed, and no false positive mutations were identified in 20 control samples. Eight single nucleotide polymorphisms were also readily detected. DNA chip-based assays may provide a valuable new technology for high-throughput cost-efficient detection of genetic alterations.Keywords
This publication has 25 references indexed in Scilit:
- Extensive polymorphisms observed in HIV–1 clade B protease gene using high–density oligonucleotide arraysNature Medicine, 1996
- Germline BRCA1 185delAG mutations in Jewish women with breast cancerThe Lancet, 1996
- Germ-LineBRCA1Mutations in Jewish and Non-Jewish Women with Early-Onset Breast CancerNew England Journal of Medicine, 1996
- Specific cloning of human DNA as yeast artificial chromosomes by transformation-associated recombination.Proceedings of the National Academy of Sciences, 1996
- Cystic fibrosis mutation detection by hybridization to light‐generated DNA probe arraysHuman Mutation, 1996
- Rapid detection of BRCA1 mutations by the protein truncation testNature Genetics, 1995
- Frontometaphyseal dysplasia: Neonatal radiographic diagnosisAmerican Journal of Medical Genetics, 1995
- A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screeningPublished by American Medical Association (AMA) ,1995
- Risks of cancer in BRCA1-mutation carriersThe Lancet, 1994
- Familial breast-ovarian cancer locus on chromosome 17q12-q23The Lancet, 1991